Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

JAK2V617F and CALR double mutations are more frequently encountered in patients with low JAK2V617F allelic burdens.

Leukemia & lymphoma - 1 Aug 2016

Mansier Olivier, Migeon Marina, Etienne Gabriel, Bidet Audrey, Lippert Eric

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to CALR gene
Share to Janus Kinase 2
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Thrombocythemia, Essential

Source

Identifiers

PMID: 26727159
DOI: 10.3109/10428194.2015.1116122

Genes

CALR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

JAK2V617F and CALR double mutations are more frequently encountered in patients with low JAK2V617F allelic burdens.PMID 26727159Read ↗

JAK2 V617F and CALR mutations are not mutually exclusive; findings from retrospective analysis of a small patient cohort.Semantic proximity Read ↗

A report on the co-occurrence of JAK2V617F and CALR mutations in myeloproliferative neoplasm patients.Semantic proximity Read ↗

Acquisition of JAK2 V617F to CALR-mutated clones accelerates disease progression and might enhance growth capacity.Semantic proximity Read ↗

Myeloproliferative neoplasms with a low (<5%) CALR mutation allele burden.Semantic proximity Read ↗

Co-occurrence of JAK2 V617F and an uncommon CALR del (p.K368fs*51) mutation facilitates JAK2/STAT signaling in polycythemia vera.Semantic proximity Read ↗

Genetic and Clinical Characteristics of Patients with Philadelphia-Negative Myeloproliferative Neoplasm Carrying Concurrent Mutations in JAK2V617F, CALR, and MPL.Semantic proximity Read ↗

Clinicopathological differences exist between CALR- and JAK2-mutated myeloproliferative neoplasms despite a similar molecular landscape: data from targeted next-generation sequencing in the diagnostic laboratory.Semantic proximity Read ↗

Essential Thrombocythemia Associated With Germline JAK2 G571S Variant and Somatic CALR Type 1 Mutation.Semantic proximity Read ↗

Clinical and biological characterization of patients with low (0.1-2%) JAK2V617F allele burden at diagnosisSemantic proximity Read ↗

Molecular testing for JAK2, MPL, and CALR in myeloproliferative neoplasms.Semantic proximity Read ↗

Study of CALR, MPL, and c-kit Gene Mutations in Thai Patients with JAK2 V617F Negative Myeloproliferative Neoplasms.Semantic proximity Read ↗

Frequency of JAK2V617F, MPL and CALR driver mutations and associated clinical characteristics in a Norwegian patient cohort with myeloproliferative neoplasms.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.